NVIDIA has released Nemotron 3 Ultra, an Agent Toolkit, and the NemoClaw framework — a simultaneous push to make autonomous AI agents viable at enterprise scale.1
Nemotron 3 Ultra delivers 5x faster inference and up to 30% lower cost for complex agentic tasks compared to prior models.1 CrowdStrike and Palantir are already deploying Nemotron for long-running AI agents in cybersecurity and operational decision-making.1
NemoClaw targets engineering software. Cadence, Dassault Systèmes, Siemens, and Synopsys are using it to build autonomous AI engineers for EDA — electronic design automation, one of the most labor-intensive domains in enterprise software.1
Jensen Huang stated that AI agents will become the largest users of computing.1 The claim positions this infrastructure as production-ready, not experimental.
The economic logic is direct. Firms deploying autonomous agents in knowledge-intensive workflows — chip design, cybersecurity, industrial simulation — can compress labor cost curves without proportional headcount growth. Analysts tracking CrowdStrike, Palantir, Cadence, and Synopsys will watch R&D headcount growth rates and gross margins over the next three quarters as early indicators.1
EDA is a meaningful test case. Chip design is iterative, bottlenecked by engineer availability, and verification-heavy. Autonomous AI engineers built on NemoClaw could compress design cycles or reduce verification load — margin effects would show up in operating leverage data before they appear in headlines.
Cybersecurity follows the same pattern. CrowdStrike and Palantir operate in domains where analyst capacity limits response speed. Long-running autonomous agents change that constraint without adding headcount.
The Agent Toolkit gives developers a structured framework for building and deploying agents across enterprise environments. Combined with Nemotron 3 Ultra's inference performance, the stack directly addresses the two barriers that have slowed enterprise AI adoption: latency and total cost of ownership.
Explicit AI agent cost-savings disclosures on earnings calls — not product announcements — will be the first hard evidence of whether the cost thesis holds for adopters over the next two to three quarters.1